iTeos Therapeutics, Inc.
ITOS
$7.35
$0.162.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -19.33% | -96.72% | -280.66% | -1,274.64% | -216.54% |
| Total Depreciation and Amortization | 37.86% | 27.85% | 21.71% | 15.98% | 11.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.62% | 30.92% | 11.14% | -1.36% | -15.40% |
| Change in Net Operating Assets | 311.92% | 74.85% | 74.58% | 104.40% | 96.15% |
| Cash from Operations | 5.37% | -0.24% | -0.90% | 3.64% | 6.69% |
| Capital Expenditure | 44.94% | -70.54% | -246.81% | -356.87% | -216.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -271.27% | 81.42% | 107.57% | 108.09% | 116.99% |
| Cash from Investing | -280.50% | 80.83% | 106.78% | 107.28% | 116.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10,925.88% | 10,850.13% | 10,945.45% | -52.43% | 20.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -146.08% | -- | -- | -- |
| Cash from Financing | 10,883.02% | 5,508.39% | 5,557.68% | -75.01% | -43.90% |
| Foreign Exchange rate Adjustments | 46.42% | -309.42% | 40.55% | 54.95% | 57.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -224.59% | 85.34% | 106.07% | 86.86% | 94.04% |
